IL126598A - Process for preparing 21-chloro corticosteroids - Google Patents

Process for preparing 21-chloro corticosteroids

Info

Publication number
IL126598A
IL126598A IL12659895A IL12659895A IL126598A IL 126598 A IL126598 A IL 126598A IL 12659895 A IL12659895 A IL 12659895A IL 12659895 A IL12659895 A IL 12659895A IL 126598 A IL126598 A IL 126598A
Authority
IL
Israel
Prior art keywords
steroids
chloro
delta
corticosteroids
preparing
Prior art date
Application number
IL12659895A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL126598A publication Critical patent/IL126598A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
IL12659895A 1994-06-01 1995-05-30 Process for preparing 21-chloro corticosteroids IL126598A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/252,302 US5502222A (en) 1994-06-01 1994-06-01 Process for preparing delta 9,11 and 21-chloro corticosteroids
IL11391895A IL113918A (en) 1994-06-01 1995-05-30 Process for preparing delta 9, 11 corticosteroids

Publications (1)

Publication Number Publication Date
IL126598A true IL126598A (en) 2003-07-31

Family

ID=22955451

Family Applications (5)

Application Number Title Priority Date Filing Date
IL12659795A IL126597A (en) 1994-06-01 1995-05-30 PROCESS FOR PREPARING Delta 9, 11 CORTICOSTEROIDS
IL12659895A IL126598A (en) 1994-06-01 1995-05-30 Process for preparing 21-chloro corticosteroids
IL11391895A IL113918A (en) 1994-06-01 1995-05-30 Process for preparing delta 9, 11 corticosteroids
IL12659898A IL126598A0 (en) 1994-06-01 1998-10-15 Process for preparing 21-chloro corticosteroids
IL12659798A IL126597A0 (en) 1994-06-01 1998-10-15 Process for preparing delta 9,11 corticosteroids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL12659795A IL126597A (en) 1994-06-01 1995-05-30 PROCESS FOR PREPARING Delta 9, 11 CORTICOSTEROIDS

Family Applications After (3)

Application Number Title Priority Date Filing Date
IL11391895A IL113918A (en) 1994-06-01 1995-05-30 Process for preparing delta 9, 11 corticosteroids
IL12659898A IL126598A0 (en) 1994-06-01 1998-10-15 Process for preparing 21-chloro corticosteroids
IL12659798A IL126597A0 (en) 1994-06-01 1998-10-15 Process for preparing delta 9,11 corticosteroids

Country Status (18)

Country Link
US (3) US5502222A (de)
EP (3) EP0969011B1 (de)
JP (1) JP2831472B2 (de)
KR (4) KR100226568B1 (de)
AT (3) ATE188481T1 (de)
AU (1) AU696425B2 (de)
CA (1) CA2191324C (de)
DE (3) DE69535765D1 (de)
DK (1) DK0063054T3 (de)
ES (3) ES2306487T3 (de)
FI (3) FI118801B (de)
GR (1) GR3032714T3 (de)
HU (3) HU227378B1 (de)
IL (5) IL126597A (de)
MX (1) MX9605893A (de)
NZ (1) NZ287348A (de)
PT (1) PT763054E (de)
WO (1) WO1995032989A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5502222A (en) * 1994-06-01 1996-03-26 Schering Corporation Process for preparing delta 9,11 and 21-chloro corticosteroids
DK0973791T3 (da) 1995-12-11 2007-09-17 Searle Llc Fremgangsmåde til fremstilling af en epoxyforbindelse
US6887991B1 (en) * 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
DK0944644T3 (da) 1996-12-11 2003-02-03 Searle & Co Fremgangsmåde til fremstilling af 3-keto-7-alfa-alkoxycarbonyl-delta-4,5-steroider og mellemprodukter, som er nyttite derfor
CN100473660C (zh) * 2002-03-22 2009-04-01 法玛西雅厄普约翰美国公司 制备依匹乐酮的方法
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
US7700603B2 (en) 2003-12-15 2010-04-20 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7592348B2 (en) 2003-12-15 2009-09-22 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
WO2008073365A1 (en) 2006-12-12 2008-06-19 Schering Corporation Aspartyl protease inhibitors
EP2805720B1 (de) 2008-05-28 2019-08-07 ReveraGen BioPharma, Inc. Nichthormonale steroide Modulatoren von NF-KB zur Behandlung von Erkrankungen
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
CN102225959B (zh) * 2011-04-29 2012-11-07 中国科学院上海有机化学研究所 一种16β-甲基-17α-羟基孕甾-3,20-二酮化合物及其合成方法
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
CN107840865A (zh) * 2016-09-20 2018-03-27 天津金耀集团有限公司 一种甲泼尼龙的制备方法
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions
US10953257B2 (en) 2019-04-19 2021-03-23 Kidde Technologies, Inc. Fire suppression composition
US11326998B2 (en) 2019-04-19 2022-05-10 Kidde Technologies, Inc. System and method for monitoring a fire suppression blend
EP4134373A1 (de) 2021-08-12 2023-02-15 Santhera Pharmaceuticals (Schweiz) AG Synthese von delta-9,11-steroiden

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE28369E (en) * 1957-02-27 1975-03-18 Atcc-zxs
US3947409A (en) * 1958-06-19 1976-03-30 Merck & Co., Inc. 16-Alkyl-1,4,9(11)-pregnatrienes and 9,11-epoxides thereof
DE1127895B (de) * 1958-12-24 1962-04-19 Ciba Geigy Verfahren zur Herstellung von reinen 9 (11)-ungesaettigten Steroiden
US3284477A (en) * 1963-07-10 1966-11-08 Schering Corp Diuretic 1, 4, 9(11)-pregnatrienes
US3639434A (en) * 1967-02-02 1972-02-01 Boots Pure Drug Co Ltd 17-acyloxysteroids and their manufacture
US3933799A (en) * 1969-01-29 1976-01-20 Glaxo Laboratories Limited 11β-Halo-9,12-unsubstituted-C19 -steroids
GB1504133A (en) * 1975-02-24 1978-03-15 Palladino G 2-bromo-6beta-fluoro-pregnane compounds
GB1504134A (en) * 1975-02-25 1978-03-15 Palladino G 2-bromo-6beta-fluoro-pregnane compounds
BG33738A3 (en) * 1978-01-25 1983-04-15 Schering Aktiengesellschaft Method for obtaining of substituated in 17- th position steroids from pregnan row
US4261984A (en) * 1978-04-05 1981-04-14 Syntex (U.S.A.) Inc. 17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
DE3640709A1 (de) * 1986-11-28 1988-06-09 Schering Ag Verfahren zur herstellung von 6(alpha),9(alpha)-difluor-11ss,17(alpha)-dihydroxy-16(alpha)-methyl-4-pregnen-3,20-dion und dessen derivate
US4920216A (en) * 1987-05-28 1990-04-24 The Trustees Of Columbia In The City Of New York Selective chlorination of steroids and other substrates directed by covalently linked pyridine derivatives acting as templates
US5502222A (en) * 1994-06-01 1996-03-26 Schering Corporation Process for preparing delta 9,11 and 21-chloro corticosteroids

Also Published As

Publication number Publication date
EP0969012B1 (de) 2008-05-14
HU227378B1 (en) 2011-05-30
CA2191324A1 (en) 1995-12-07
JPH09506113A (ja) 1997-06-17
FI117599B (fi) 2006-12-15
AU2603595A (en) 1995-12-21
ATE397008T1 (de) 2008-06-15
ATE188481T1 (de) 2000-01-15
KR100290227B1 (ko) 2001-05-15
NZ287348A (en) 1998-12-23
IL126597A (en) 2003-09-17
GR3032714T3 (en) 2000-06-30
EP0969012A3 (de) 2004-10-06
HUT75518A (en) 1997-05-28
HU1000527D0 (en) 2010-11-29
JP2831472B2 (ja) 1998-12-02
FI118801B (fi) 2008-03-31
WO1995032989A1 (en) 1995-12-07
EP0763054B1 (de) 2000-01-05
HU227380B1 (en) 2011-05-30
EP0969011A3 (de) 2004-10-06
FI964739A (fi) 1996-11-28
HU9603299D0 (en) 1997-01-28
DE69514352D1 (de) 2000-02-10
IL113918A (en) 1999-12-31
ES2306488T3 (es) 2008-11-01
IL113918A0 (en) 1995-08-31
US5616742A (en) 1997-04-01
US5750745A (en) 1998-05-12
FI20050181A (fi) 2005-02-16
FI117600B (fi) 2006-12-15
EP0969011B1 (de) 2008-05-28
KR100290225B1 (ko) 2001-05-15
ATE395353T1 (de) 2008-05-15
IL126597A0 (en) 1999-08-17
EP0763054A1 (de) 1997-03-19
ES2140678T3 (es) 2000-03-01
HU227379B1 (en) 2011-05-30
FI20050180A (fi) 2005-02-16
PT763054E (pt) 2000-06-30
KR100290226B1 (ko) 2001-05-15
DE69514352T2 (de) 2000-08-24
KR100226568B1 (ko) 1999-10-15
AU696425B2 (en) 1998-09-10
IL126598A0 (en) 1999-08-17
ES2306487T3 (es) 2008-11-01
EP0969011A2 (de) 2000-01-05
US5502222A (en) 1996-03-26
HU0302654D0 (en) 2003-10-28
DE69535756D1 (de) 2008-06-26
DE69535765D1 (de) 2008-07-10
MX9605893A (es) 1997-12-31
CA2191324C (en) 2001-08-28
FI964739A0 (fi) 1996-11-28
EP0969012A2 (de) 2000-01-05
DK0063054T3 (da) 2000-06-19

Similar Documents

Publication Publication Date Title
FI20050181A (fi) Menetelmä valmistaa 21-kloorikortikosteroideja
EP0164636A3 (en) A process for the preparation of 16,17 acetals of pregnane derivatives and compounds obtained therefrom
FR1434426A (fr) Procédé pour la préparation d'androst-4-ène-3, 17-dione et d'androsta-1, 4-diène-3, 17-dione à partir de stéroïdes à l'aide de microorganismes
HU9301633D0 (en) New method for producing 11-keto-steroide derivatives
EP0231950A3 (de) Verfahren zur nichtlinearen A/D-Wandlung
GR81987B (de)
PFUFF Representation of cracks by dislocations and its application to the fracture toughness of metals
Danilenko et al. Reconstruction of a 250(10 in.) Rod Mill to Produce High Duty Rod
JPS5436543A (en) Transient stability improving system
ES478942A1 (es) Un procedimiento para la conversion selectica de 20-metil- pregna-3,5,20(21)-trino-3,2-diol-diacetato en 3-oxo-metil- pregna-4,20(21)-dieno-21-il-acetato.
Pshenishnyu The Process of Forging by Rolling, Special Equipment, and the Method for Designing and Technological Calculations
HUT72588A (en) New 16-(substituted methyl)-pregna-1,4-diene-3,20-dione derivatives and process for producing them
JPS6469222A (en) Power controlling method for inverter
JPS5529272A (en) Cyclo converter
JPS5463253A (en) Reactive power adjusting device
PL263783A1 (en) Method of obtaining 6-alpha-fluoro-16-alpha,17-alpha-isopropylidenedioxy-11-betha,21-dihydroxy-4-pregnene-3,20-dione

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees